International Extranodal Lymphoma Study Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Bellinzona Switzerland (1997)

Organization Overview

First Clinical Trial
2000
NCT00210379
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

International Extranodal Lymphoma Study Group (IELSG) | International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona | International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland (IOSI)